Delivery Order SPE2DE24D0013-SPE2D626F25D4
- Not listed
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $2,482.28 by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This firm fixed-price delivery order, designated as XPRSMVP-10, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract utilizes no set-aside designation, reflecting Cepheid's competitive...
- Cepheid Inc. was awarded a firm fixed-price delivery order valued at $1,750 by the Defense Logistics Agency Medical Supply Chain on December 15, 2025, with an ultimate completion date of December 22, 2025. This delivery order, issued under contract GXMRSA-NXG-10, requires performance in Sunnyvale, California, where Cepheid maintains its headquarters. The contract contains no set-aside designation, reflecting Cepheid's competitive positioning in the federal molecular diagnostics procurement...
- Cepheid Inc., headquartered in Sunnyvale, California, has been awarded a delivery order valued at $1,680 with an ultimate completion date of November 13, 2025, by the Defense Logistics Agency Medical Supply Chain. This firm fixed-price delivery order, issued without a set-aside designation, represents a continuation of Cepheid's ongoing role as a primary federal supplier of molecular diagnostic solutions. As a manufacturer of advanced diagnostic systems and reagents, Cepheid supplies the federal...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a firm fixed-price delivery order valued at $9,216.80 by the Defense Logistics Agency Medical Supply Chain on December 10, 2025, with an ultimate completion date of December 17, 2025. This delivery order, designated XPRSMVP-10 (Contract Number 4570254413), represents a continuation of the federal government's reliance on Cepheid's diagnostic capabilities. The contract utilizes no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a firm fixed-price delivery order (XPRSMVP-10) valued at $4,608.40 by the Defense Logistics Agency Medical Supply Chain on December 4, 2025, with an ultimate completion date of December 11, 2025. This delivery order, issued with no set-aside designation, represents a continuation of Cepheid's role as a primary federal supplier of molecular diagnostic systems and reagents. The contract is performed at Cepheid's Sunnyvale,...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $40,946.80 firm fixed-price delivery order by the Defense Logistics Agency Medical Supply Chain on December 2, 2025, with an ultimate completion date of December 9, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, pertains to molecular diagnostic reagents and test cartridges for detecting COVID-19, influenza, and respiratory syncytial virus using Cepheid's GeneXpert diagnostic platform. The contract carries no...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a delivery order valued at $1,382.52 by the Defense Logistics Agency Medical Supply Chain on November 12, 2025, with an ultimate completion date of November 19, 2025. This firm fixed-price delivery order, designated XPRSMVP-10, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. As a leading federal supplier of advanced molecular diagnostic systems and reagents, Cepheid has...
- Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $2,040 delivery order (Contract No. 4570200483, XPRS4PLEX-10) by the Defense Logistics Agency Medical Supply Chain on December 5, 2025, with an ultimate completion date of December 12, 2025. This firm fixed-price delivery order, which carries no set-aside designation, is for molecular diagnostic testing supplies and reagents for the GeneXpert diagnostic platform. The award represents a continuation of Cepheid's established...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of advanced molecular diagnostic systems, was awarded a delivery order valued at $2,039.40 by the Defense Logistics Agency's Medical Supply Chain on October 22, 2025, with a completion deadline of November 5, 2025. This firm fixed-price delivery order carries no set-aside designation and represents work to be performed at the contractor's Sunnyvale location. The award falls under the Defense Logistics Agency's procurement operations, which...
- Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, was awarded a delivery order valued at $2,765.04 on December 16, 2025, under the Defense Logistics Agency Medical Supply Chain contract vehicle. This firm fixed-price delivery order, designated XPRSMVP-10, is scheduled for completion by December 23, 2025, and will be performed at Cepheid's Sunnyvale facility. The award includes no small business set-aside designation, reflecting Cepheid's established competitive...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D626F25D4Delivery Order
Cepheid Inc., headquartered in Sunnyvale, California, was awarded a $4,500 delivery order (contract number GXMRSA-NXG-10) by the Defense Logistics Agency's Medical Supply Chain on December 16, 2025, with an ultimate completion date of December 23, 2025. This firm fixed-price delivery order, which carries no set-aside designation, represents a continuation of the federal government's reliance on Cepheid's molecular diagnostic solutions. The place of performance is located in Sunnyvale, California, where Cepheid manufactures its GeneXpert diagnostic platform and associated reagents and test kits used across multiple federal healthcare agencies. Cepheid has established itself as a primary federal supplier of advanced molecular diagnostic systems and reagents for detecting infectious diseases, serving the Department of Veterans Affairs, Indian Health Service, Defense Health Agency, and U.S. Coast Guard among others. The company holds significant indefinite delivery contracts with the VA, including a $32.8 million single-award IDC with VISN 6 extending through September 2030 and a $6.7 million IDC with VISN 17 through December 2029, which serve as the framework for ongoing procurement of molecular diagnostic testing capabilities across the federal healthcare system. These contracts underscore Cepheid's competitive positioning in the federal diagnostics procurement market and its critical role in supporting infectious disease testing requirements across distributed VA medical center networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.5k | 12/15/25 |